Posted in | Medical Robotics

Hansen Medical Accelerates Development of Magellan 3Fr Robotic Microcatheter

Hansen Medical, Inc., the global leader in intravascular robotics, today announced it has accelerated the development of the latest addition to the Magellan Robotic System portfolio, the Magellan 3Fr Robotic Microcatheter. The development of this important product line expansion has surpassed key milestones and is moving toward the final stages of the development process.

Hansen Medical continues to experience procedural growth with the current Magellan product portfolio and recently surpassed the 1000th procedure performed with the Magellan Robotic System.

"This is an exciting time for Hansen Medical," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "Significant effort has been applied to the development of the Magellan 3Fr Robotic Catheter and it represents a major clinical and commercial opportunity for the organization. As an appreciably smaller robotic catheter, the Magellan 3Fr may enable physicians to navigate to smaller, more challenging anatomy. Further, this capability may open up larger market opportunities such as applications for neuro and coronary intervention, cancer treatment and limb salvage. We are equally delighted by the successful completion of our 1000th procedure with Magellan, further demonstrating our continued penetration of the market and physician satisfaction with our robotic platform," continued Vance.

The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy. Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel1. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95% in complex endovascular procedures2.

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedures globally. The Magellan Robotic System offers several important features including:

  • Provides predictability, control and catheter stability as a physician navigates a patient's peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices.
  • Is designed to enable more predictable procedure times and increased case throughput potentially allowing hospitals to improve utilization within their vascular business line.
  • Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation field and without wearing heavy lead as required in conventional endovascular procedures.
  • The Magellan 9Fr and 10Fr Robotic Catheters allow for independent, robotic control of two telescoping catheters (an outer Guide and an inner Leader catheter), as well as robotic manipulation of standard guide wires.
  • The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires. This smaller catheter design may be preferred by certain physicians who prefer a smaller diameter vessel access site, or in procedures in smaller vessels.

Source: http://www.hansenmedical.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hansen Medical. (2019, February 19). Hansen Medical Accelerates Development of Magellan 3Fr Robotic Microcatheter. AZoRobotics. Retrieved on December 10, 2019 from https://www.azorobotics.com/News.aspx?newsID=8074.

  • MLA

    Hansen Medical. "Hansen Medical Accelerates Development of Magellan 3Fr Robotic Microcatheter". AZoRobotics. 10 December 2019. <https://www.azorobotics.com/News.aspx?newsID=8074>.

  • Chicago

    Hansen Medical. "Hansen Medical Accelerates Development of Magellan 3Fr Robotic Microcatheter". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=8074. (accessed December 10, 2019).

  • Harvard

    Hansen Medical. 2019. Hansen Medical Accelerates Development of Magellan 3Fr Robotic Microcatheter. AZoRobotics, viewed 10 December 2019, https://www.azorobotics.com/News.aspx?newsID=8074.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit